Headlines Specialties Covid-19 Trending Feeds ASCO20 Videos

Pembrolizumab plus nab-paclitaxel active as salvage strategy in urothelial carcinoma


Urology Times - Given the efficacy and safety demonstrated, there may be a role going forward for the pembrolizumab/nab-paclitaxel combination in earlier disease